For instance, the GNAQ mutation frequency is approximately 80–90% in uveal melanoma, and the p.Q209 (glutamine 209) mutation triggers a loss of GTPase activity, enabling permanent and oncogenic downstream signaling [25]. Here, GNAQ is linked to uveal melanoma.